GenScript Bio (01548): CARVYKTI's fourth quarter trade sales revenue is approximately 334 million US dollars.
Kingsley Biotechnology (01548) released an announcement regarding the collaboration between Legend Biotech and Janssen Biotech...
GENSCRIPT BIO (01548) announced that, based on the cooperation and licensing agreement entered into by Legend Biotech and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI is expected to generate approximately $334 million in trade sales revenue by the end of the quarter ending December 31, 2024.
Related Articles
A-share announcement highlights | Hangzhou Silan Microelectronics (600460.SH) landed a 20 billion yuan chip project.
TIANGONG INT'L (00826) signs strategic cooperation agreement with Saivida to jointly promote the new development of high-end die-casting materials technology.
HSC RESOURCES (01850): Zhou Yunhui and Xuan Chaohui will be appointed as independent non-executive directors.
A-share announcement highlights | Hangzhou Silan Microelectronics (600460.SH) landed a 20 billion yuan chip project.
TIANGONG INT'L (00826) signs strategic cooperation agreement with Saivida to jointly promote the new development of high-end die-casting materials technology.
HSC RESOURCES (01850): Zhou Yunhui and Xuan Chaohui will be appointed as independent non-executive directors.
RECOMMEND
